| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 17,165 | 1 | | Cost of Revenue |
-
|
-
| | | Gross Profit | 17,165 | 1 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 1,627 | 1 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 15,538 | 1 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| | Earnings Before Interest And Taxes | 15,538 | 1 | | Interest Expense | 0 | 1 | | Income Before Tax | 15,538 | (0) | | Income Tax Expense | 5,438 |
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 10,100 | (0) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 10,100 | (0) | | Preferred Stock And Other Adjustments | (2,772) |
-
| | | Net Income Applicable To Common Shares | $7,328 | ($0) |
|
0.20% Nasdaq 
Income Statement
